| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,235 |
14,690 |
$2.88M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,393 |
7,846 |
$2.80M |
| X4011 |
State-specific procedure code |
8,233 |
7,499 |
$2.49M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,735 |
7,354 |
$1.92M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,108 |
27,292 |
$1.18M |
| 80053 |
Comprehensive metabolic panel |
25,557 |
23,304 |
$786K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,171 |
4,938 |
$776K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,185 |
5,017 |
$523K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,040 |
9,216 |
$510K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
982 |
944 |
$273K |
| 71046 |
Radiologic examination, chest; 2 views |
1,965 |
1,792 |
$244K |
| 81001 |
|
6,092 |
5,751 |
$238K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,404 |
604 |
$236K |
| J3490 |
Unclassified drugs |
3,902 |
3,025 |
$225K |
| 71045 |
Radiologic examination, chest; single view |
4,937 |
4,620 |
$215K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,165 |
2,021 |
$205K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,870 |
2,659 |
$163K |
| 36415 |
Collection of venous blood by venipuncture |
7,198 |
6,125 |
$159K |
| Y7507 |
|
812 |
716 |
$139K |
| 84484 |
|
5,805 |
5,110 |
$105K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,833 |
1,672 |
$103K |
| 86900 |
|
601 |
567 |
$100K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,118 |
1,092 |
$96K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,148 |
1,122 |
$96K |
| 86850 |
|
620 |
582 |
$82K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,118 |
734 |
$79K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,623 |
2,482 |
$77K |
| 86901 |
|
600 |
566 |
$76K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,383 |
4,190 |
$69K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
310 |
301 |
$62K |
| Y7506 |
|
488 |
399 |
$56K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
999 |
911 |
$54K |
| 80061 |
Lipid panel |
2,391 |
2,266 |
$53K |
| X4006 |
|
47 |
44 |
$51K |
| 70450 |
Computed tomography, head or brain; without contrast material |
371 |
351 |
$46K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
69 |
69 |
$43K |
| 83690 |
|
2,594 |
2,469 |
$41K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
534 |
178 |
$38K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,111 |
1,072 |
$32K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
164 |
157 |
$26K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
334 |
306 |
$23K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
155 |
151 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,513 |
1,417 |
$19K |
| 81003 |
|
1,400 |
1,351 |
$19K |
| 76830 |
Ultrasound, transvaginal |
94 |
92 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
161 |
139 |
$18K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
660 |
615 |
$16K |
| 87660 |
|
673 |
648 |
$16K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
83 |
81 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
275 |
254 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
139 |
125 |
$15K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
303 |
293 |
$14K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
165 |
160 |
$13K |
| 87480 |
|
497 |
477 |
$13K |
| 87631 |
|
43 |
40 |
$13K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
72 |
71 |
$12K |
| 83605 |
|
552 |
513 |
$11K |
| 87081 |
|
118 |
117 |
$11K |
| 87510 |
|
352 |
339 |
$11K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
24 |
24 |
$11K |
| 87430 |
|
49 |
48 |
$11K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
288 |
283 |
$11K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
72 |
63 |
$10K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
135 |
134 |
$9K |
| 84702 |
|
469 |
351 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
859 |
832 |
$8K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
172 |
171 |
$8K |
| 84703 |
|
393 |
386 |
$7K |
| 86803 |
|
106 |
105 |
$6K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
51 |
50 |
$6K |
| 97597 |
|
53 |
40 |
$5K |
| 80081 |
|
72 |
72 |
$5K |
| 87420 |
|
15 |
14 |
$5K |
| G0378 |
Hospital observation service, per hour |
33 |
30 |
$5K |
| 84439 |
|
257 |
249 |
$5K |
| 86780 |
|
12 |
12 |
$5K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
163 |
158 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
119 |
112 |
$3K |
| 82077 |
|
199 |
182 |
$3K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
105 |
103 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
58 |
55 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
24 |
24 |
$2K |
| 85379 |
|
204 |
199 |
$2K |
| 83880 |
|
92 |
84 |
$1K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
88 |
24 |
$1K |
| 83655 |
|
24 |
24 |
$1K |
| 86592 |
|
178 |
176 |
$673.71 |
| 87040 |
|
44 |
42 |
$550.26 |
| 85027 |
|
88 |
86 |
$501.41 |
| 80143 |
|
42 |
38 |
$451.60 |
| 82043 |
|
82 |
76 |
$407.24 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
32 |
27 |
$387.17 |
| 82570 |
|
84 |
78 |
$350.58 |
| 80179 |
|
30 |
27 |
$289.52 |
| 82950 |
|
55 |
52 |
$233.04 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
13 |
$230.59 |
| 82803 |
|
13 |
12 |
$208.50 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
40 |
37 |
$204.32 |
| 82550 |
|
39 |
37 |
$187.55 |
| 81025 |
|
13 |
13 |
$105.28 |
| 86140 |
|
17 |
13 |
$76.65 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16 |
13 |
$59.36 |
| 85730 |
|
14 |
12 |
$53.37 |
| 85610 |
|
18 |
16 |
$42.68 |
| 85652 |
|
17 |
13 |
$39.90 |
| 82962 |
|
15 |
13 |
$31.44 |
| J2704 |
Injection, propofol, 10 mg |
24 |
12 |
$27.11 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
12 |
12 |
$16.79 |